Publications by authors named "Naoshi Obara"

Claim this Profile
T
Tumor necrosis factor from leukemic environment stimulates hematopoietic stem/progenitor cells toward megakaryocyte/myeloid lineage bias.
Hidekazu Nishikii, Riko Kikuchi, Takaharu Kimura, Mizuki Saito, Yusuke Kiyoki, Naoshi Obara

Exp Hematol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A retrospective analysis of autologous stem cell transplantation conditioning with reduced-dose busulfan/thiotepa for patients with central nervous system lymphomas at a single institution.
Keiichiro Hattori, Naoki Kurita, Fumiaki Matsumura, Kenichi Makishima, Sakurako Suma, Naoshi Obara

Int J Hematol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eltrombopag-Induced Falsely Elevated Bilirubin Concentrations in Enzymatic and Vanadate Oxidation Assays: Involvement of High Serum Eltrombopag Concentrations.
Shun Oda, Kosuke Doki, Naoshi Obara, Yoshiharu Suzuki, Shigeru Chiba

Ther Drug Monit· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Case report: Spontaneous remission of severe aplastic anemia mediated by mutant hematopoietic stem cells evading T-cell attack.
Kohei Shiroshita, Yoshitaka Zaimoku, Himari Kudo, Naoshi Obara, Kazuyoshi Hosomichi

Front Immunol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiple Myeloma in a Patient with Birt-Hogg-Dubé Syndrome.
Fumiaki Matsumura, Tatsuhiro Sakamoto, Hirayasu Kai, Toshiaki Usui, Kunio Kawanishi, Naoshi Obara

Intern Med· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of Delayed Initiation of Lenalidomide Maintenance Therapy After Allogeneic Hematopoietic Stem Cell Transplantation for Multiple Myeloma.
Koji Kawamura, Nobuhiro Tsukada, Shun-Ichi Kimura, Shinichi Kako, Daisuke Minakata, Naoshi Obara

Hematol Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment burden in patients with paroxysmal nocturnal hemoglobinuria: an in-depth interview survey.
Yasutaka Ueda, Naoshi Obara, Shikiko Ueno, Masatoshi Sakurai, Kohei Hosokawa

Ann Hematol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Data on the p.Gly17Val RHOA Mutation in Diagnosing T Follicular Helper Cell Lymphomas.
Yuri Tsuboi, Keiichiro Hattori, Naoki Kurita, Yasuhito Suehara, Toru Nanmoku, Naoshi Obara

Cancer Med· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Successful BTK inhibitor therapy for refractory transformed B-cell lymphoma originating from an MYD88 mutant clone].
Atsushi Uehara, Hidekazu Nishikii, Yasuhito Suehara, Ryota Matsuoka, Toru Nanmoku, Naoshi Obara

Rinsho Ketsueki· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term safety and effectiveness of romiplostim for chronic idiopathic thrombocytopenic purpura in real-world settings.
Naoshi Obara, Shigeki Hatanaka, Yukie Tsuji, Koji Higashi

Int J Hematol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Beyond Recycling Antibodies: Crovalimab's Molecular Design Enables Four-Weekly Subcutaneous Injections for PNH Treatment.
Zenjiro Sampei, Kenta Haraya, Siok Wan Gan, Masaru Muraoka, Akira Hayasaka, Naoshi Obara

Int J Mol Sci· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 3 randomized COMMODORE 2 trial: Crovalimab versus eculizumab in patients with paroxysmal nocturnal hemoglobinuria naive to complement inhibition.
Alexander Röth, Guangsheng He, Hongyan Tong, Zenghua Lin, Xiaoqin Wang, Naoshi Obara

Am J Hematol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 2, open-label study of ibrutinib plus rituximab in Japanese patients with Waldenstrom's macroglobulinemia.
Koji Izutsu, Hisashi Kato, Naohiro Sekiguchi, Tomoaki Fujisaki, Toshiro Kawakita, Naoshi Obara

Int J Hematol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Current trends in the treatment of aplastic anemia].
Naoshi Obara

Rinsho Ketsueki· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of CD34 positive cell dose in donor graft on the outcomes after haploidentical peripheral blood stem cell transplantation with post-transplant cyclophosphamide - A retrospective single-center study with a Japanese cohort.
Yumiko Maruyama, Hidekazu Nishikii, Naoki Kurita, Tatsuhiro Sakamoto, Keiichiro Hattori, Naoshi Obara

Blood Cells Mol Dis· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Burden of illness in Japanese patients with paroxysmal nocturnal hemoglobinuria receiving C5 inhibitors.
Naoshi Obara, Kensuke Usuki, Takeshi Hayashi, Masato Fujii, Takayuki Ikezoe

Int J Hematol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Durable remission of T-cell prolymphocytic leukemia with CLEC16A::IL2 after allogeneic hematopoietic stem cell transplantation].
Haruka Momose, Naoki Kurita, Hidekazu Nishikii, Nozomi Yusa, Kazuaki Yokoyama, Naoshi Obara

Rinsho Ketsueki· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Female and preserved platelet count subgroups of myelodysplastic syndrome patients benefit from standard-dose azacitidine.
Shinichi Ogawa, Tatsuhiro Sakamoto, Ryota Matsuoka, Kantaro Ishitsuka, Yasuko Ogino, Naoshi Obara

Cancer Rep (Hoboken)· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Repeated immunosuppressive rabbit antithymocyte globulin therapy for adult patients with relapsed or refractory aplastic anemia.
Tatsuhiro Sakamoto, Naoshi Obara, Yumiko Maruyama, Takayasu Kato, Naoki Kurita

Eur J Haematol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A longitudinal analysis of paroxysmal nocturnal haemoglobinuria-type cells in patients with bone marrow failure: Results of a prospective multi-centre study in Japan.
Ken Ishiyama, Yuji Yonemura, Tatsuya Kawaguchi, Kohei Hosokawa, Chiharu Sugimori, Naoshi Obara

Br J Haematol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety of romiplostim administered immediately after cord-blood transplantation: a phase 1 trial.
Naoki Kurita, Hidekazu Nishikii, Yumiko Maruyama, Yasuhito Suehara, Keiichiro Hattori, Naoshi Obara

Ann Hematol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interim analysis of post-marketing surveillance of ravulizumab for paroxysmal nocturnal hemoglobinuria in Japan.
Kensuke Usuki, Takayuki Ikezoe, Ken Ishiyama, Yoshinobu Kanda, Akihiko Gotoh, Naoshi Obara

Int J Hematol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Crovalimab treatment in patients with paroxysmal nocturnal haemoglobinuria: Long-term results from the phase I/II COMPOSER trial.
Alexander Röth, Satoshi Ichikawa, Yoshikazu Ito, Jin Seok Kim, Zsolt Nagy, Naoshi Obara

Eur J Haematol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The fatty acid elongase Elovl6 is crucial for hematopoietic stem cell engraftment and leukemia propagation.
Yusuke Kiyoki, Takayasu Kato, Sakura Kito, Takashi Matsuzaka, Shin Morioka, Naoshi Obara

Leukemia· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Lymphoplasmacytic lymphoma accompanied by severe myelofibrosis].
Ayako Takarada, Haruka Momose, Naoki Kurita, Ryota Matsuoka, Naoya Nakamura, Naoshi Obara

Rinsho Ketsueki· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis